Vol. 10, Issue 8, Part C (2024)

Abstract
Waste management is of the utmost importance in protecting human lives and the environment. With the expansion of the Pharmaceutical Industry over the years, India has recognised the necessity for strong bio-medical waste management legislation; nevertheless, its execution is still far from ideal. According to the ASSOCHAM- Velocity MR Report, India will generate 77.5 tonnes of medical waste per day by 2022, based on the current estimated waste level of 550.9 tonnes per day growing at a compound annual growth rate, and the waste management market in India will likely reach US$ 13.62 billion by 2025. 4 On January 31, 2020, India recorded its first case of coronavirus, and in less than three months we had surpassed 10,000 instances. The present study Is based on secondary data, secondary data collected from annual report Annual Report on Biomedical Waste Management as per Biomedical Waste Management Rules, 2016for the year 2020, central and state pollution control board, ASSOCHAM, and CBWTFs. The study uses the table and graphs to analyse the collected data. The study found the COVID-19 has contributed the bio waste management I India, there is gap between the BMW waste generation and treatment. There is a issues and challenges in the implementation of Biomedical Waste Management Rules, 2016.